1/5Vitro Biopharma, Inc.: Filing-delay notice, quarterly report filed within extension (NT 10-Q)

Market data

n/a: no ticker symbol on the filing.

Verified excerpt

"Vitro Biopharma Inc. (the "Company") has determined that it is unable to file its Quarterly Report on Form 10-Q for the quarter ended April 30, 2025 by the original due date for such filing, without unreasonable effort or expense because it requires additional time to complete its financial statements. The Company expects that it will file the Form 10-Q no later than June 19, 2025."

Quoted from the filing. Source

What this means

The company filed Form NT 10-Q, telling the SEC it could not file its quarterly report on time, and then filed the report within the 5-day extension. The SEC treats a report filed within the extension as timely, so this is the mildest kind of flag, but the notice itself is a warning sign that investors often react to: something, often the audit or the accounting, took longer than planned.

Status: filed within extension (report filed 2025-06-20) · the SEC treats a report filed within the extension as timely

Why this score: report filed within the extension on 2025-06-20